Search research articles
Contact Us
Filters
Showing results (21-30 of 80) with videos related to
Page
of 8
Sort By:
Journal of Chemotherapy (Florence, Italy)
|
June 2, 2006
Home infusions of biphosphonate in cancer patients: a prospective study
A Italiano, C Ciais, E Chamorey, et al.
Anti-Cancer Drugs
|
June 23, 1999
Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea: an experimental study on human glioblastoma cell lines
K Ilc, J M Ferrero, J L Fischel, et al.
Bulletin Du Cancer
|
March 1, 1995
[Combination of mitoxantrone-vinorelbine as first-line chemotherapy for metastatic breast carcinoma]
J M Ferrero, X Pivot, M Namer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2001
Epidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-up
J M Ferrero, A Ramaioli, R Largillier, et al.
Oncology
|
April 18, 2008
Haematological evaluation of weekly therapy with topotecan for the treatment of recurrent ovarian cancer resistant to platinum-based therapy
R Largillier, B Valenza, J-M Ferrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2014
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)
A Awada, I N Bondarenko, J Bonneterre, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1996
Age-related difference in tamoxifen disposition
F Peyrade, M Frenay, M C Etienne, et al.
Public Health Genomics
|
April 11, 2013
Breast cancer patients' views on the use of genomic testing to guide decisions about their postoperative chemotherapy
V Seror, P Marino, F Bertucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2007
Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients
S Oudard, E Banu, F Scotte, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
|
January 1, 1992
[Seraspenide (acetylSDKP): phase I-II trial study of inhibitor of hematopoiesis protects against toxicity of aracytine and ifosfamide monochemotherapies]
P Carde, C Chastang, E Goncalves, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 80) with videos related to
Sort By:
Page
of 8
Journal of Chemotherapy (Florence, Italy)
|
June 2, 2006
Home infusions of biphosphonate in cancer patients: a prospective study
A Italiano, C Ciais, E Chamorey, et al.
Anti-Cancer Drugs
|
June 23, 1999
Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea: an experimental study on human glioblastoma cell lines
K Ilc, J M Ferrero, J L Fischel, et al.
Bulletin Du Cancer
|
March 1, 1995
[Combination of mitoxantrone-vinorelbine as first-line chemotherapy for metastatic breast carcinoma]
J M Ferrero, X Pivot, M Namer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2001
Epidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-up
J M Ferrero, A Ramaioli, R Largillier, et al.
Oncology
|
April 18, 2008
Haematological evaluation of weekly therapy with topotecan for the treatment of recurrent ovarian cancer resistant to platinum-based therapy
R Largillier, B Valenza, J-M Ferrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2014
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)
A Awada, I N Bondarenko, J Bonneterre, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1996
Age-related difference in tamoxifen disposition
F Peyrade, M Frenay, M C Etienne, et al.
Public Health Genomics
|
April 11, 2013
Breast cancer patients' views on the use of genomic testing to guide decisions about their postoperative chemotherapy
V Seror, P Marino, F Bertucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2007
Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients
S Oudard, E Banu, F Scotte, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
|
January 1, 1992
[Seraspenide (acetylSDKP): phase I-II trial study of inhibitor of hematopoiesis protects against toxicity of aracytine and ifosfamide monochemotherapies]
P Carde, C Chastang, E Goncalves, et al.
Page
of 8